• Market cap: $2.73 T
  • 24H Vol: $84.90 B
  • BTC Dominance: 58.5%

Coinspeaker: crypto news

Partners

PRESS RELEASES

Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research
By • 4 mins read
Press Release

Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research

By • 4 mins read

Molecule, a decentralised biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfully transferred to research collective VitaDAO to fund novel longevity therapeutics at the University of Copenhagen.

1 848 849 850 1,250